SIMULTANEOUS ASSAY FOR CHOLESTEROL AND TRIGLYCERIDES
    131.
    发明申请
    SIMULTANEOUS ASSAY FOR CHOLESTEROL AND TRIGLYCERIDES 审中-公开
    同时测定胆固醇和胆固醇

    公开(公告)号:WO1989002925A1

    公开(公告)日:1989-04-06

    申请号:PCT/US1988003169

    申请日:1988-09-20

    CPC classification number: C12Q1/61 C12Q1/60

    Abstract: A method for the simultaneous determination of cholesterol and triglyceride substrates with a single reagent system. The reagent system is reacted with the specimen such that each of the substrates reacts with their respective reactant simultaneously. The change in absorbance or fluorescence of the resulting reaction mixture is measured at a plurality of wavelengths which are characteristic for each of the substrates to be determined. The amount of cholesterol and triglyceride substrates can be determined by either an endpoint or reaction rate measurement. The reagent system comprises an enzyme having cholesterol esterase activity, a chromogenic oxygen acceptor, microperoxidase, and cholesterol oxidase for determination of cholesterol; and lipase, ATP, PEP, glycerol kinase, pyruvate kinase, LDH and NAD(P)H or analogs thereof for determination of triglyceride.

    Abstract translation: 用单一试剂系统同时测定胆固醇和甘油三酯底物的方法。 试剂系统与样品反应,使得每个底物同时与其各自的反应物反应。 所得到的反应混合物的吸光度或荧光的变化是在要确定的每个基底的特征的多个波长下测量的。 胆固醇和甘油三酯底物的量可以通过终点或反应速率测量来确定。 试剂系统包括具有胆固醇酯酶活性的酶,显色氧受体,微过氧化物酶和用于测定胆固醇的胆固醇氧化酶; 和脂肪酶,ATP,PEP,甘油激酶,丙酮酸激酶,LDH和NAD(P)H或其类似物以测定甘油三酸酯。

    TRICYCLIC ERYTHROMYCIN DERIVATIVES
    133.
    发明申请
    TRICYCLIC ERYTHROMYCIN DERIVATIVES 审中-公开
    三硫化红霉素衍生物

    公开(公告)号:WO1998030574A1

    公开(公告)日:1998-07-16

    申请号:PCT/US1997005871

    申请日:1997-04-07

    CPC classification number: C07H17/08 C07H17/00

    Abstract: Compounds, or pharmaceutically acceptable salts and esters thereof, of formulas: (I); (II); (III); or (IV); wherein A, B, D and E, R , R , and Z specifically defined, having antibacterial activity, pharmaceutical compositions containing said compounds, treatment of bacterial infections with such compositions, and processes for the preparation of the compounds.

    Abstract translation: 化合物或其药学上可接受的盐和酯,其具有下式:(I); (II); (III); 或(IV); 其特征在于具有抗菌活性的A,B,D和E,R 1,R 2和Z,含有所述化合物的药物组合物,用这些组合物治疗细菌感染,以及制备化合物的方法 。

    CRYSTAL FORM I OF CLARITHROMYCIN
    138.
    发明申请
    CRYSTAL FORM I OF CLARITHROMYCIN 审中-公开
    克拉霉素的晶体形式

    公开(公告)号:WO1998004573A1

    公开(公告)日:1998-02-05

    申请号:PCT/US1997013128

    申请日:1997-07-25

    CPC classification number: C07H17/08

    Abstract: The present invention concerns the novel antiobiotic 6-O-methylerythromycin A crystal Form I, a process for its preparation, pharmaceutical compositions comprising this compound and a method of use as a therapeutic agent.

    Abstract translation: 本发明涉及新型抗生素6-O-甲基红霉素A晶型I,其制备方法,包含该化合物的药物组合物和用作治疗剂的方法。

    NUCLEIC ACID PRIMERS AND PROBES FOR DETECTING MYCOPLASMA PNEUMONIAE
    139.
    发明申请
    NUCLEIC ACID PRIMERS AND PROBES FOR DETECTING MYCOPLASMA PNEUMONIAE 审中-公开
    用于检测MYCOPLASMA PNEUMONIAE的核酸引物和探针

    公开(公告)号:WO1998000565A2

    公开(公告)日:1998-01-08

    申请号:PCT/US1997010884

    申请日:1997-06-23

    CPC classification number: C12Q1/689 Y10S435/81

    Abstract: Nucleic acid sequences that are useful for detecting Mycoplasma pneumoniae are herein provided. These sequences can be used in hybridization assays or amplification based assays designed to detect the presence of Mycoplasma pneumoniae in a test sample. Additionally, the sequences can be provided as part of a kit.

    Abstract translation: 本文提供了可用于检测肺炎支原体的核酸序列。 这些序列可用于设计用于检测测试样品中肺炎支原体存在的杂交测定或基于扩增的测定。 另外,序列可以作为试剂盒的一部分提供。

Patent Agency Ranking